Laobaimin Pharmacy (listed on the main board of the Shanghai Stock Exchange, stock code 603883) is an influential pharmaceutical retail chain enterprise in China, the champion of China's top 100 pharmaceutical retail enterprises in terms of comprehensive competitiveness, the top 500 enterprises in China's service industry, and the top 100 enterprises in Hunan Province.

Since its establishment in 2001, it has successfully developed 20 provincial-level markets such as Hunan, Shaanxi, Zhejiang, and Jiangsu, with 10,000 stores, total assets of 16.958 billion yuan, 40,000 employees, and sales of 15.696 billion yuan (excluding tax) in 2021. The ultimate goal of the people's pharmacy is to build a "century-old store", and seek sustainable development of the enterprise while pursuing the maximization of social value, to this end, Mr. Xie Zilong, chairman of the board of directors, put forward the "three good treatment" ideas of "treating customers, suppliers, and employees", hoping to make unremitting efforts with consumers, suppliers and employees for a common better and healthier cause.